InterAx Biotech develops novel therapies by translating complex biology into breakthrough medicines using its Deep Signal™ platform. This platform integrates mathematical modeling, experimental methods, and machine learning to decipher cell signaling language, enabling the design of highly efficacious small molecule drug candidates targeting GPCRs. InterAx serves to generate high-efficacy leads and improve drug profiles by understanding disease impact before pre-clinical trials.